House dust mite subcutaneous immunotherapy has sustained long‐term effectiveness on allergic rhinitis and asthma: A 10‐year follow‐up

BACKGROUND: Maintenance doses for allergen immunotherapy (AIT) have been recommended for at least 3 years but little data on long‐term efficacy is available depending on AIT duration. To show sustained efficacy 10 years after completion of treatment with depigmented‐polymerized house dust mite (dpg‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez‐Plata, Elena, Callero Viera, Ariel, Ruiz‐Garcia, Monica, Gomez‐Cardenosa, Aida, Nieto, Eva, García‐Robaina, Jose Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571497/
https://www.ncbi.nlm.nih.gov/pubmed/37904678
http://dx.doi.org/10.1002/iid3.1004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571497/
https://www.ncbi.nlm.nih.gov/pubmed/37904678
http://dx.doi.org/10.1002/iid3.1004

Ejemplares similares